Navigation Links
INC Research to Acquire Kendle International for $15.25 per Share in Cash
Date:5/4/2011

s for the emerging drug development outsourcing and alliance partnership models," said James Ogle, CEO of INC Research.  "Together, we bring complementary strengths and expand the breadth and depth of services and expertise that are most valuable to our customers."  

The combination of INC Research and Kendle strengthens both businesses by creating a global CRO with significant therapeutic capability and geographic diversity.  The combined company will rank among the top-tier CROs based on size and scale, and will be well positioned to handle large-scale global trials.

As a result of the proposed merger transaction, Kendle's earnings release and conference call/webcast scheduled for Thursday, May 5, at 8 a.m. Eastern Time has been cancelled.  In addition, Kendle's Annual Meeting of Shareholders has been postponed from May 19, 2011, with a new date to be determined by Kendle's Board of Directors.

In connection with the transaction, J.P. Morgan Securities LLC acted as Kendle's financial advisor and Keating, Muething & Klekamp PLL acted as its legal advisor.  Morgan Stanley & Co. Inc. acted as financial advisor and Weil Gotshal & Manges LLP acted as the legal advisor to INC Research.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry.  Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing products to market for the benefit of patients worldwide.  As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeut
'/>"/>

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. In Battle Against Healthcare Associated Infections: Continuing Research on Friendly Bacteria
2. HistoRx Announces Launch of New Research Services: AQUAPrep™ and Access AQUA® Services Now Available
3. Harvard Medical School Faculty Advances Drug Safety Research With IBM Business Analytics
4. Uroplasty to Present at the JMP Securities Research Conference
5. Solta Medical to Present at the JMP Securities Research Conference
6. SeraCare Life Sciences Announces Renewal of National Institutes of Health Contract to Support Research
7. Biodesix Supports Unique Lung Cancer Research Initiative
8. Chronic Disease Research Group Study Shows Daily Home Hemodialysis Therapy with the NxStage® System One™ is Associated with Lower Risk of Mortality and Higher Survival Estimates Compared to Conventional Thrice-Weekly Dialysis
9. Central European Society for Anticancer Drug Research Announces Start of Enrollment in First Randomized Trial of Pharmacokinetic-Guided Dose Adjustment of Paclitaxel in Non-Small Cell Lung Cancer
10. Cetero Research Names 25-Year Industry Veteran James Dixon to Head Quality and Compliance
11. Cetero Research Seminars Provide Insights on Designing Accelerated Proof-of-Concept Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, ... Global Biotechnology, Inc. for the compounding, packaging and distributing of ... in the United States . ... capable of compounding naltrexone tablets in various strengths for individual ...
(Date:1/23/2015)... Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned itself ... share and grab a foothold in the hydroponic, hemp and ... and a presence in the sector, and recently partnering with ... of hemp and medical marijuana, iMD is committing to bring ...
(Date:1/23/2015)... Jan. 23, 2015  Mallinckrodt plc (NYSE: MNK ... approved a share repurchase program. The open-ended authorization permits ... Mallinckrodt plc ordinary shares. "Funding additional ... priorities as we continue to pursue a range of ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... Clinical Trials for Organ Transplantation, HORSHOLM, Denmark, May ... I clinical results for,its transplantation product candidate, LCP-Tacro ... organ transplantation. , Today LifeCycle Pharma A/S (OMX:LCP) ... program of LCP-Tacro, a,proprietary, once-daily tacrolimus tablet. , ...
... at the Pediatric Academic Societies' Annual Meeting,This Month ... Pulse,Oximetry Technology Can Reduce the Risk Associated with ... /PRNewswire/ -- Masimo, the,inventor of Pulse CO-Oximetry and ... a new independent study,presented at the Pediatric Academic ...
Cached Medicine Technology:LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 2LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 3Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology,Shown to Significantly Lower Instances of Severe Retinopathy of,Prematurity in Extremely Low Birth Weight Infants 2Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology,Shown to Significantly Lower Instances of Severe Retinopathy of,Prematurity in Extremely Low Birth Weight Infants 3Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology,Shown to Significantly Lower Instances of Severe Retinopathy of,Prematurity in Extremely Low Birth Weight Infants 4
(Date:1/22/2015)... (PRWEB) January 23, 2015 VogueQueen is a ... affordable prices and many designers are thrilled to have it ... business announces its new collection of prom dresses for the ... to drive the strategic vision and he focuses on continuing ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
(Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy ... its highest annual revenues in the past three years. Today, ... wedding dresses. , According to the sales manager of the ... for them in 2015. This point can be reflected on ...
(Date:1/22/2015)... As interest in the value of spiritual support ... Rev. Eric J. Hall , president and CEO of ... be the keynote speaker on January 27 at an international ... , The conference, “Hope and Resilience: Innovative and Interdisciplinary Spiritual ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
... a common side effect- cough. Iron supplementation cures the ... blood pressure medication. , The angiotensin-converting enzyme (ACE) inhibitors ... failure and other cardiac conditions. But up to 40% ... cough. The side effect is not considered serious by ...
... in Germany have developed a new risk assessment methodology ... patient's risk of cardiac death. , ECG is the ... can be determined and analysed by the computer.The time ... be calculated.// When the programme has completed its analysis, ...
... starch, previously thought to be just 'empty calories', actually helps ... Organisation (CSIRO), researchers have revealed that resistant starch could be ... , , ... China have low rates of bowel cancer even though they ...
... small amounts of alcohol consumption is linked with deliquent ... new study. ,Dr. Virginia Delaney-Black, of Children's Hospital ... out with the finding that in comparison to the ... a week during pregnancy were three times more likely ...
... slimming FDA approved drug which can actually works. Not only that ... slimming. This wonder slimming drug is XENICAL. ,Xenical allows ... pass through the gut undigested. Your body cannot convert these excess ... energy. This will therfore help you to reduce your weight, maintain ...
... biopsy detecting technique for prostate cancers has been found out ... traditional examination. In the traditional exam for prostate cancer, the ... , At Ohio State University, researchers said that it is ... team, called this the extended sector biopsy. They ...
Cached Medicine News:
... 463 is a quality control material that, ... performance of blood gas, electrolyte, metabolite, and ... to the use of human blood in ... (3) levels for monitoring analyzer performance at ...
Molteno3 Glaucoma Drainage Device incorporates the latest advances from Professor Moltenos glaucoma research. It has been extensively tested since early 2004 and gives even better control of intraocu...
... way to capture and process ultrasound images, ... a revolutionary advancement. The z.one platform, powered ... Convertible Ultrasound system, instantly converting from a ... ultrasound system with all the performance of ...
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
Medicine Products: